Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.

Margaroni M, Agallou M, Athanasiou E, Kammona O, Kiparissides C, Gaitanaki C, Karagouni E.

Int J Nanomedicine. 2017 Aug 23;12:6169-6184. doi: 10.2147/IJN.S141069. eCollection 2017.

2.

Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.

Zarogoulidis P, Athanasiou E, Tsiouda T, Hatzibougias D, Huang H, Bai C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Barbetakis N, Paliouras D, Rapti A, Drougas D, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Aug 29;22:197-202. doi: 10.1016/j.rmcr.2017.08.017. eCollection 2017.

3.

Endobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case series.

Zarogoulidis P, Huang H, Bai C, Kosmidis C, Trakada G, Veletza L, Tsiouda T, Barbetakis N, Paliouras D, Athanasiou E, Hatzibougias D, Kallianos A, Panagiotopoulos N, Papaemmanouil L, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Aug 19;22:187-196. doi: 10.1016/j.rmcr.2017.08.016. eCollection 2017.

4.
5.

Designed positively charged cyclodextrin hosts with enhanced binding of penicillins as carriers for the delivery of antibiotics: The case of oxacillin.

Agnes M, Thanassoulas A, Stavropoulos P, Nounesis G, Miliotis G, Miriagou V, Athanasiou E, Benkovics G, Malanga M, Yannakopoulou K.

Int J Pharm. 2017 Oct 15;531(2):480-491. doi: 10.1016/j.ijpharm.2017.04.080. Epub 2017 May 1.

PMID:
28473235
6.

Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.

Agallou M, Margaroni M, Athanasiou E, Toubanaki DK, Kontonikola K, Karidi K, Kammona O, Kiparissides C, Karagouni E.

PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005311. doi: 10.1371/journal.pntd.0005311. eCollection 2017 Jan.

7.

Coincidence of thymoma and breast cancer and in a 56-year-old female patient.

Athanasiou E, Michalopoulou-Manoloutsiou E, Bobos M, Hatzibougias DI, Zarogoulidis P, Katsikogiannis N, Sarika E, Karapantzos I, Barbetakis N, Paliouras D, Chatzinikolaou F, Charalampidis C, Kougioumtzi I, Kolettas A, Bakas A, Tzelepi K, Kalaitzis E, Tsakiridis K.

Ann Transl Med. 2016 Nov;4(22):446. doi: 10.21037/atm.2016.11.34.

8.

Gold nanoparticle-based lateral flow biosensor for rapid visual detection of Leishmania-specific DNA amplification products.

Toubanaki DK, Athanasiou E, Karagouni E.

J Microbiol Methods. 2016 Aug;127:51-58. doi: 10.1016/j.mimet.2016.05.027. Epub 2016 May 30.

PMID:
27255490
9.

Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis.

Agallou M, Athanasiou E, Samiotaki M, Panayotou G, Karagouni E.

PLoS One. 2016 Feb 23;11(2):e0149894. doi: 10.1371/journal.pone.0149894. eCollection 2016.

10.

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.

Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC; HERMES study group.

PLoS One. 2015 Mar 20;10(3):e0119755. doi: 10.1371/journal.pone.0119755. eCollection 2015.

11.

Medical patients' treatment decision making capacity: a report from a general hospital in Greece.

Bilanakis N, Vratsista A, Athanasiou E, Niakas D, Peritogiannis V.

Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:133-9. doi: 10.2174/1745017901410010133. eCollection 2014.

12.

Superior long-term repopulating capacity of G-CSF+plerixafor-mobilized blood: implications for stem cell gene therapy by studies in the Hbb(th-3) mouse model.

Psatha N, Sgouramali E, Gkountis A, Siametis A, Baliakas P, Constantinou V, Athanasiou E, Arsenakis M, Anagnostopoulos A, Papayannopoulou T, Stamatoyannopoulos G, Yannaki E.

Hum Gene Ther Methods. 2014 Dec;25(6):317-27. doi: 10.1089/hgtb.2014.005.

13.

Rare benign tumours of the nipple.

Spyropoulou GA, Pavlidis L, Trakatelli M, Athanasiou E, Pazarli E, Sotiriadis D, Demiri E.

J Eur Acad Dermatol Venereol. 2015 Jan;29(1):7-13. doi: 10.1111/jdv.12623. Epub 2014 Aug 14. Review.

PMID:
25124255
14.

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Agallou M, Athanasiou E, Koutsoni O, Dotsika E, Karagouni E.

Front Immunol. 2014 Jun 10;5:268. doi: 10.3389/fimmu.2014.00268. eCollection 2014.

15.

Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.

Tsolaki E, Athanasiou E, Gounari E, Zogas N, Siotou E, Yiangou M, Anagnostopoulos A, Yannaki E.

Blood Cells Mol Dis. 2014 Sep;53(3):124-32. doi: 10.1016/j.bcmd.2014.05.003. Epub 2014 Jun 10.

PMID:
24923531
16.

Response to "Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing breast tumors".

Vassiou K, Tsougos I, Kousi E, Vlychou M, Athanasiou E, Theodoru K, Arvanitis DL, Fezoulidis IV.

Acta Radiol. 2014 May;55(4):418-9. doi: 10.1177/0284185113503529. No abstract available.

PMID:
24757186
17.

Laparoscopic ventral hernia repair in obese patients under spinal anesthesia.

Symeonidis D, Baloyiannis I, Georgopoulou S, Koukoulis G, Athanasiou E, Tzovaras G.

Int J Surg. 2013;11(9):926-9. doi: 10.1016/j.ijsu.2013.07.002. Epub 2013 Jul 13.

18.

KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen.

Tzouvelekis LS, Miriagou V, Kotsakis SD, Spyridopoulou K, Athanasiou E, Karagouni E, Tzelepi E, Daikos GL.

Antimicrob Agents Chemother. 2013 Oct;57(10):5144-6. doi: 10.1128/AAC.01052-13. Epub 2013 Jul 15.

19.

Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.

Vassiou K, Tsougos I, Kousi E, Vlychou M, Athanasiou E, Theodorou K, Arvanitis DL, Fezoulidis IV.

Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.

PMID:
23436823
20.

Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.

Piperis M, Provatopoulou X, Sagkriotis A, Kalogera E, Ampatzoglou E, Zografos GC, Athanasiou E, Gounaris A.

Anticancer Res. 2012 Nov;32(11):4993-5002.

PMID:
23155270

Supplemental Content

Loading ...
Support Center